Reuters logo
BRIEF-Crystal Genomics receives U.S. patent
September 13, 2017 / 2:20 AM / a month ago

BRIEF-Crystal Genomics receives U.S. patent

Sept 13 (Reuters) - Crystal Genomics Inc :

* Says it received U.S. patent on Sep. 13, for 2,3-dihydro-isoindole-1-on derivative as btk kinase suppressant, and pharmaceutical composition including same

Source text in Korean: goo.gl/j1wMbi

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below